Research24 May 2023· 3 min read
Biotechnology: Shaping the Future of Medicine Through Innovation
In today's rapidly advancing world, biotechnology has emerged as a powerful force, propelling medical science into uncharted territories and promising a brighter future for healthcare. This multidisci
By Dr. Eleanor Vance, Regulatory Affairs Editor
Research21 May 2023· 3 min read
Pearls for Clinical, Ketamine
Amidst a burgeoning body of research, we're continually unravelling new facets of the versatile drug ketamine. A case in point is recent studies indicating another feather in ketamine's cap: treating
By Tom Okafor, Clinical Trials Correspondent
Research6 May 2023· 3 min read
Fulfilling the Potential of Drug R&D: Six Predictions for 2023
As the world becomes increasingly reliant on pharmaceuticals to treat a wide range of diseases, the importance of drug research and development (R&D) continues to grow. In recent years, there have
By Tom Okafor, Clinical Trials Correspondent
Research20 April 2023· 3 min read
The Power of Partnership: How Emerging Biotechs Strengthen Their Commercialization Journey
In the fast-paced world of biotech, emerging companies are always looking for ways to stand out and make their mark. One key strategy they're using is to form strategic partnerships with other compani
By Dr. Eleanor Vance, Regulatory Affairs Editor
Research17 April 2023· 6 min read
Sterile Manufacturing and Lyophilization Capabilities of Large and Small Molecule Biologics
The pharmaceutical industry has seen a significant rise in the demand for biologics, which are drugs produced from living organisms. As the demand for biologics continues to grow, so does the need for
By Dr. Eleanor Vance, Regulatory Affairs Editor
Research23 March 2023· 4 min read
Researchers Reset Aging Process - Rejuvenating cells
After 13 years of research, Dr David Sinclair and his team have made a breakthrough discovery regarding ageing. Sinclair, a genetics professor at Harvard Medical School and co-director of the Paul F.
By Dr. Eleanor Vance, Regulatory Affairs Editor
Research3 March 2023· 3 min read
Lilly's £630M Investment in Novartis' Failed Pain Target.
In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big breakthrough drug. The quest for new treatments can be a risky and expensive endeavour, with no gu
By Tom Okafor, Clinical Trials Correspondent
Research8 January 2023· 3 min read
Clinical trial for the cancer mRNA vaccine has over
Years of preclinical and clinical trials on mRNA vaccines for cancer therapy have laid the groundwork for making mRNA vaccines during the COVID-19 pandemic. The inherent benefit of ease of production,
By Tom Okafor, Clinical Trials Correspondent
Research16 December 2022· 2 min read
A universal flu vaccination might prevent a pandemic in the future.
Researchers claim to have made progress in developing a vaccine that will protect against all 20 forms of influenza. The effective Covid vaccines employ the same messenger-ribonucleic acid (mRNA) tech
By Dr. Eleanor Vance, Regulatory Affairs Editor
Research8 December 2022· 6 min read
Lecanemab, an Alzheimer's medication, is heralded as a major development.
It has been called "historic" that the first drug to slow the brain damage caused by Alzheimer's has been made. The scientific discovery puts a stop to decades of futility and demonstrates that new me
By Dr. Eleanor Vance, Regulatory Affairs Editor